Cannabinoid CB 1 receptor (via G s ) and dopamine D 2 receptor (via G i0o ) antagonistically modulate goldfish cone membrane currents. As ON bipolar cells have CB 1 and D 1 receptors, but not D 2 receptors, we focused on whether CB 1 receptor agonist and dopamine interact to modulate voltage-dependent outward membrane K ϩ currents I K(V) of the ON mixed rod0cone (Mb) bipolar cells. Whole-cell currents were recorded from Mb bipolar cells in goldfish retinal slices. Mb bipolar cells were identified by intracellular filling with Lucifer yellow. The bath solution was calcium-free and contained 1 mM cobalt to block indirect calcium-dependent effects. Dopamine (10 mM) consistently increased I K(V) by a factor of 1.57 6 0.12 (S.E.M., n ϭ 15). A CB receptor agonist, WIN 55212-2 (0.25-1 mM), had no effect, but 4 mM WIN 55212-2 suppressed I K(V) by 60%. If I K(V) was first increased by 10 mM dopamine, application of WIN 55212-2 (0.25-1 mM) reversibly blocked the effect of dopamine even though these concentrations of WIN 55212-2 had no effect of their own. If WIN 55212-2 was applied first and dopamine (10 mM) was added to the WIN-containing solution, 0.1 mM WIN 55212-2 blocked the effect of dopamine. All effects of WIN 55212-2 were blocked by coapplication of SR 141716A (CB 1 antagonist) and pretreatment with pertussis toxin (blocker of G i0o ) indicating action via CB 1 receptor activation of G protein G i0o . Coactivation of CB 1 and D 1 receptors on Mb bipolar cells produces reciprocal effects on I K(V) . The CB 1 -evoked suppression of I K(V) is mediated by G protein G i0o , whereas the D 1 -evoked enhancement is mediated by G protein G s . As dopamine is a retinal "light" signal, these data support our notion that endocannabinoids function as a "dark" signal, interacting with dopamine to set retinal sensitivity.
Introduction
Dopamine and endogenous cannabinoids function as neurotransmitters as well as neuromodulators in the brain, in which they often have opposing effects on nerve function. Early studies showed in rodents that a cannabinoid receptor 1 (CB 1 receptor) agonist injected to the striatum produced immobility (Gough & Olley, 1978) , while a dopamine receptor agonist increased motor activity (Woolverton & Kleven, 1988) . In vivo studies provided numerous examples of interactions between cannabinoid and dopamine D 1 receptor systems (Navarro et al., 1993; Rodriguez De Fonseca et al., 1994; Anderson et al., 1995 Anderson et al., , 1996 Sanudo-Pena et al., 1998) . On a cellular level, cannabinoids affect the neuronal activity of dopamine neurons in the ventral tegmental area (French, 1997; Gessa et al., 1998; Cheer et al., 2003; Patel & Hillard, 2003) . Activation of D 1 receptors increases the activity of adenyl cyclase so as to increase cyclic AMP formation and stimulate cAMPdependent protein kinase (e.g., Greengard et al., 1998, for review) . However, activation of CB 1 receptors has dual effects. It can either inhibit or stimulate adenylate cyclase via G i0o or G s, respectively (Glass & Felder, 1997; Bonhaus et al., 1998; Shire et al., 1999) . CB 1 and D 1 receptors can interact at the level of G-protein0 adenylyl cyclase signal transduction (Meschler & Howlett, 2001) . Dopamine and endocannabinoid systems are also found in the retina. There is a very extensive literature on dopamine function in the retina. Progressive deterioration of visual function in Parkinson's disease patients, judged by both electrophysiological and psychophysical testing (see review Rodnitzky, 1998) , includes changes in color vision (Birch et al., 1998; Muller et al., 1999; Pieri et al., 2000) , contrast sensitivity (Kupersmith et al., 1982; Bodis-Wollner, 1990) , electroretinographic patterns, and visually evoked potentials (Bodis-Wollner, 1997; Langheinrich et al., 2000) . Those abnormalities often respond to levadopa therapy indicating they are related to dopamine deficiency that likely includes a significant retinal component (Harnois & Di Paolo, 1990; NguyenLegros et al., 1993; Bodis-Wollner & Antal, 1995) . Cannabinoids have been suggested to affect photosensitivity, visual acuity, and color match limits (Kiplinger et al., 1971; Dawson et al., 1977; Consroe et al., 1997; Russo et al., 2004) . It is likely that some of the psychophysical effects of cannabinoids are mediated in the retina because of growing evidence from a variety of disciplines for a retinal endocannabinoid system (e.g., Schlicker et al., 1996; Straiker et al., 1999; Yazulla et al., 1999 Yazulla et al., , 2000 Straiker & Sullivan, 2003; Savinainen & Laitinen, 2004; Fan & Yazulla, 2003 .
CB 1 receptors are found on the synaptic terminals of the two glutamatergic classes of retinal neuron: photoreceptors and bipolar cells (Straiker et al., 1999; Yazulla et al., 1999 Yazulla et al., , 2000 . In goldfish cones, the CB 1 receptors are coexpressed with dopamine D 2 receptors (Yazulla & Lin, 1995; Yazulla et al., 2000) . We found, in goldfish cones, that low concentrations of CB 1 agonist WIN 55212-2 enhanced voltage-dependent potassium (I K(V) ) and calcium currents (I Ca ) by G protein G s , and that D 2 receptor activation suppressed this effect by G i0o (Fan & Yazulla, 2004) . CB 1 receptors are also found on the plasma membrane of the synaptic terminal of ON Mb bipolar cells (Yazulla et al., 2000) . However, unlike cones that possess D 2 receptors that inhibit adenylate cyclase, Mb bipolar cells possess D 1 receptors that stimulate adenylate cyclase (Heidelberger & Matthews, 1994; Mora-Ferrer et al., 1999) . The purpose of this study was to investigate whether the antagonistic interaction between CB 1 and dopamine receptors would be the same or different for cones and Mb bipolar cells. The results show that activation of CB 1 and D 1 receptors on Mb bipolar cells are antagonistic regarding voltage-dependent potassium current I K(V) . However, the effect of CB 1 receptor activation is reversed: I K(V) is suppressed in Mb bipolar cells by G i0o , rather than enhanced as in cones by G s . The opposing action of dopamine is mediated by D 1 receptors in Mb bipolar cells, rather than by D 2 receptors as in cones.
Material and methods

Animals
Goldfish (Carassius auratus), 8-10 cm body length, were stored in aquaria at 228C on a 12-h on012-h off light cycle. Water was aerated and circulated continuously through a polyester fiber0 charcoal filter system. Fish were fed with Total Goldfish Flakes (Wardly Co., Secaucus, NJ) and treated according to the guidelines of the Association for Research of Vision and Ophthalmology.
Solutions and chemicals
Calcium-activated currents in Mb bipolar cells are restricted largely to the synaptic terminals and not particularly prominent when recording from the soma of isolated cells (Heidelberger & Matthews, 1992; Tachibana et al., 1993) . As our whole-cell recordings were from the soma, we concentrated on the voltage-dependent outward K ϩ current, I K(V) . To eliminate any complication of Ca 2ϩ -activated currents, the incubation saline was calcium-free. It contained 140 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 1 mM CoCl 2 , and 10 mM HEPES, pH 7.4 adjusted with NaOH. The recordingpipette solution contained 140 mM KCl, 0.1 mM CaCl 2 , 0.6 mM ethylene-glycol-bis ( b-aminoethyl ether) 
' -tetraacetic acid (EGTA), 0.5 mM MgCl 2 , 1 mM adenosine 5 ' -triphosphate (ATP, K-salt), 1 mM guanosine 5 ' -triphosphate (GTP, Na-salt), Lucifer yellow (K-salt, saturated), and 5 mM HEPES, pH 7.4 adjusted with KOH. Dopamine hydrochloride, WIN 55212-2, MS-222, and pertussis toxin were obtained from Sigma Chemical (St. Louis, MO). The cannabinoid receptor antagonist, SR 141716A, was obtained upon request by Dr. Dale Deutsch on our behalf to the Research Triangle Institute under license from the National Institute of Drug Abuse. As ascorbate has physiological actions of its own in the fish retina (Yazulla, 1985; Fan & Yazulla, 1999a,b) , it was not included in the dopamine-containing saline. The dopamine solution was prepared just prior to use. WIN 55212-2 was dissolved in pure dimethylsulfoxide (DMSO) to make stock solutions of 10 mM. Just prior to application, the stock solution was diluted to the required concentrations with saline. During the recordings, the concentration of DMSO was kept constant before, during the application, and washout of cannabinoid agonists with saline.
In the experiments that tested the involvement of G protein G i0o , fish received a unilateral intraocular injection of pertussis toxin (PTX) 24 h prior to the experiment. Fish were anesthetized in water containing 0.02% 3-aminobenzoic acid ethyl ester (MS-222) and wrapped in wet towels; 5 ml of PTX saline solution (10 mg0ml) was injected into the eye with a 30-gauge hypodermic needle. Fish were allowed to recover in fresh tank water and then returned to a holding tank until the next day.
Preparation of retinal slices
Prior to dissection, fish were dark adapted for 1 h, killed by cervical transection, and the eyes were enucleated under dim red light. All procedures and experiments were performed and completed during subjective day, between 10 a.m. and 5 p.m. Our procedure for obtaining goldfish-retinal slices has been described elsewhere (Fan & Yazulla, 1999a,b) . Briefly, after the lens and iris were removed, the inferior one-third of the eyecup was cut, placed photoreceptor-side up on a strip of Millipore filter, after which the sclera and choroid were removed. The retina, together with the filter paper, was immersed in a solution containing 20% L-15 culture medium (GIBCO, Grand Island, NY) and 80% NaCl saline and cut into 300-mm-thick slices using a razor blade advanced by a micrometer. The slices remained in this solution for 1 h in the dark at 48C. Then, a slice, still attached to the Millipore filter, was rotated 90 deg and the two ends of the filter were embedded in petroleum-gel tracks in the experimental chamber (Model RC-22C of Warner Instrument Co., Manden, CT). The volume of solution in the chamber was about 0.3 ml. Slices were perfused with the calcium-free, NaCl saline at 228C at a rate of about 2.0 ml0min and viewed through a Zeiss 63ϫ, long working distance (1.3 mm), water-immersion objective. All drugs were bath applied by switching among reservoirs that flowed into a common perfusion tube. Bath exchange took about 2 min.
Whole-cell recording technique
Whole-cell currents were recorded with a conventional patchclamp method (Hamill et al., 1981) . Patch electrodes were pulled in two stages with a vertical electrode puller (Model PP-83, Narishige, Tokyo, Japan) using thin wall, microhematocrit capillary tubes (Fischer Scientific, Pittsburgh, PA) with an inner diameter of 1.1-1.2 mm. The tip resistance, measured in the bath, was between 3 and 10 MV; the seal resistance ranged from 1 GV to 20 GV. A patch-clamp amplifier (Model Axopatch 200A), pClamp software (version 8.0), and Digidata data acquisition instrument (Model 1322A) of Axon Instruments (Foster City, CA) were used. The junction potential was corrected (Fenwick et al., 1982) and the total access resistance was corrected (70%) with the seriesresistance correction on the patch amplifier. The digitized current data were stored in an IBM PC compatible computer. Data are presented as the mean 6 standard error of the mean (S.E.M.)
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Results
Dopamine enhanced I K(V) via dopamine D 1 receptor
Dopamine at 10 mM reversibly enhanced I K(V) when the bipolar cells were depolarized more positively than Ϫ18 mV from a holding potential of Ϫ70 mV (Figs. 1A & 1B). The enhancement of I K(V) by 10 mM dopamine was by a factor of 1.57 6 0.12 (mean 6 S.E.M., n ϭ 15) over the range of Ϫ18 to ϩ 54 mV. The enhancement of I K(V) by 10 mM dopamine was suppressed completely in the presence of D 1 receptor antagonist 2 mM SCH 23390 (Fig. 1C) , indicating that the effect of dopamine was mediated by D 1 receptors. These data corroborate our earlier findings with ascorbate, dopamine, and the D 1 agonist SKF 39393 demonstrating the D 1 -mediated enhancement of I K(V) in Mb bipolar cells (Fan & Yazulla, 1999b) .
Previously, we found that cannabinoid CB 1 receptor agonist CP 55940 (1 mM) suppressed I K(V) of goldfish Mb bipolar cells by about 40% (Yazulla et al., 2000) . However, neither the doseresponse relation nor the receptor-mediated mechanism of this suppression were determined. WIN 55212-2, another CB 1 agonist, was less effective than CP 55940 in that it had no significant effect on I K(V) at concentrations Յ 1 mM, but suppressed I K(V) by about 70%~P Ͻ 0.01) at 4 mM (Fig. 2) . Curiously, at concentrations Յ1 mM, about one-third of the cells showed an appreciable rebound after washout the drug that lasted for 10-30 min, even though the amplitude of I K(V) was not affected during drug application. During the rebound, I K(V) could increase to ;300% of the control value. With 4 mM WIN 55212-2, the amplitude of I K(V) only recovered to the control value after washout; no rebound was observed. This rebound was not studied further.
Low concentrations of WIN 55212-2 suppressed the enhancement of I K(V) by dopamine
Even though 1 mM WIN 55212-2 had no effect of its own on I K(V) (Fig. 2) , it inhibited the enhancement of I K(V) evoked by 10 mM dopamine. Figs. 3A and 3B show that after I K(V) was increased in the presence of 10 mM dopamine, the addition of 1 mM WIN 55212-2 decreased the evoked current, and in this particular cell, to below the control level. This effect was reversible with washout of both drugs. The suppressive effect of WIN 55212-2 on 10 mM dopamine-induced enhancement of I K(V) was concentration dependent (Fig. 3C) , with an increasing effect from 0.25 mM to 4 mM. The effect at 0.25 mM and 0.5 mM was not significantly different from control, whereas the effect at 1 mM and 4 mM was significantly less at the P Ͻ 0.05 and 0.01 levels, respectively.
The effect of WIN 55212-2 was mediated by cannabinoid CB 1 receptor
As illustrated in one cone in Fig. 4 , application of a CB 1 receptor antagonist, 2 mM SR 141716A, had no effect of its own on I K(V) . Also, the enhancement of I K(V) by 10 mM dopamine was not affected by the presence 2 mM SR 141716A (1.63 6 0.16, n ϭ 4) compared to the dopamine-control condition reported in Fig. 1 (1.57 6 0.12, n ϭ 15). However, in the presence of 2 mM SR 141716A, the suppressive effect of 1 mM WIN 55212-2 on the dopamine-induced enhancement of I K(V) did not occur~n ϭ 4), indicating that the effect of WIN 55212-2 was mediated by CB 1 receptors.
The suppressive effect of WIN 55212-2 was mediated via G protein G i/o
The following experiments were performed after intraocular injections of PTX (Fig. 5) . After treating the retina with PTX, the enhancement of I K(V) by 10 mM dopamine still was observed as in control conditions (enhanced by 1.65 6 0.18, n ϭ 5). However, 1 mM WIN 55212-2 no longer opposed the action of 10 mM dopamine, indicating that the action of WIN 55212-2 was mediated by cannabinoid receptor activation of G protein G i0o .
WIN 55212-2 applied before dopamine was more effective than when applied afterward
Although 1 mM WIN 55212-2 had no detectable effect on I K(V) (see Fig. 2 ), it blocked the enhancing effect of 10 mM dopamine There was a return to control with washout of drugs. Depolarizing steps were applied from a holding potential of Ϫ70 mV. The sequence of conditions is indicated, in order, by the identified symbols in the upper left side of the I-V axis. (C) WIN 55212-2 blocked the enhancing effect of 10 mM dopamine on I K(V) in a concentration-dependent manner. In these experiments, the amplitude of I K(V) was measured in response to application of 10 mM dopamine and again after the addition of the nominal concentration of WIN 55212-2, as indicated on the abscissa. Each Mb bipolar cell was subjected to only one concentration of WIN 55212-2. The effect of 10 mM dopamine was effectively negated at 1 mM WIN 55212-2 P Ͻ 0.05; n ϭ 5) and reversed to an net inhibition at 4 mM WIN 55212-2 P Ͻ 0.01; n ϭ 4). Depolarizing steps to ϩ48 mV were applied from a holding potential of Ϫ70 mV. Current amplitudes are plotted relative to that elicited in the absence of dopamine. "0" on the abscissa is the response to 10 mM dopamine in the absence of any WIN 55212-2.
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regardless of whether 1 mM WIN 55212-2 or 10 mM dopamine was present in the perfusate first. The question arose as to what was the lowest concentration of WIN 55212-2 in the perfusate that could be counteracted by the addition of 10 mM dopamine.
In the following experiments, 10 mM dopamine was added to the perfusate that contained varying concentrations of WIN 55212-2. Separate bipolar cells were recorded for each concentration of WIN 55212-2. First, stable currents were recorded in the control saline; second, a nominal concentration of WIN 55212-2 was added and currents were recorded again. Third, 10 mM dopamine was included with the WIN 55212-2 and the effect of WIN on the enhancement produced by 10 mM dopamine was determined and compared with that obtained in the absence of WIN. As illustrated in Fig. 6 , 0.05 mM WIN 55212-2 had no inhibitory effect on the presence of 10 mM dopamine. The enhancement of 1.60 6 0.18 n ϭ 6) was the same as in control conditions. However, 0.1 mM WIN 55212-2 reduced the dopamine-induced enhancement of I K(V) by ;70% to 1.2 6 0.1~P Ͻ 0.05; n ϭ 5). Furthermore, in the presence of 0.25 mM WIN 55212-2, the addition of 10 mM dopamine actually resulted in a suppression of I K(V)~P Ͻ 0.01), rather than a null effect as would be expected if 0.25 mM WIN 55212-2 simply cancelled the effect of 10 mM dopamine. This potent effect of 0.25 mM WIN 55212-2 when it preceded dopamine application was surprising because 0.25 mM WIN 55212-2 had no apparent effect on I K(V) when applied alone (Fig. 2) or applied after 10 mM dopamine (Fig. 3) .
Discussion
We have shown that coactivation of CB 1 and D 1 receptors on Mb bipolar cells produces a mutually antagonistic effect on the voltagegated outward potassium current I K(V) . The CB 1 -evoked suppression of current is mediated by G protein G i0o , whereas the D 1 -evoked enhancement is mediated by G protein G s . Fig. 4 . The effect of WIN 55212-2 is mediated by CB 1 receptors. These I-V curves show that the addition of 2 mM SR 141716A had no effect of its own on I K(V) . The addition of 10 mM dopamine to 2 mM SR 141716A still resulted in an enhancement of I K(V) . However, the addition of 1 mM WIN 55212-2 no longer inhibited the effect of dopamine. Thus, the effect of WIN 55212-2 was blocked by the presence of SR 141716A, indicating involvement of CB 1 receptors. Depolarizing steps were applied from a holding potential of Ϫ70 mV. The sequence of conditions is indicated, in order, by the identified symbols in the upper left side of the I-V axis. Fig. 5 . The effect of WIN 55212-2 is PTX sensitive. In these experiments, the retinas were obtained from eyes that received overnight injections of pertussis toxin. Addition of 10 mM dopamine still enhanced I K(V) to the same degree as in untreated retinas. However, the usual inhibitory effect of 1 mM WIN 55212-2 on the dopamine-induced enhancement of I K(V) was not observed. Thus, the effect of WIN 55212-2 was mediated by CB 1 receptor coupling to G protein G i0o . Depolarizing steps were applied from a holding potential of Ϫ70 mV. The sequence of conditions is indicated, in order, by the identified symbols in the upper left side of the I-V axis. 6 . WIN 55212-2 effectively blocked the action of dopamine when it preceded dopamine in the perfusate. After stable records were obtained, a constant concentration of WIN 55212-2, indicated on the abscissa, was added to the perfusate. The amplitude of I K(V) was then determined before and after the addition of 10 mM dopamine. The histogram shows that the presence of 0.05 mM WIN 55212-2 had no effect on the action of dopamine. However, the effect of dopamine was reduced by about 70% P Ͻ 0.05; n ϭ 5) in the presence of 0.10 mM WIN 55212-2 and completely counteracted by 0.25 mM WIN 55212-2~P Ͻ 0.01; n ϭ 4). Depolarizing steps were applied from a holding potential of Ϫ70 mV. Current amplitudes are plotted relative to that elicited in the absence of dopamine.
G protein-coupled modulators of membrane currents in ON bipolar cells
There are extensive studies on the modulation of ligand-gated conductances in ON bipolar cells by G proteins. This is best exemplified by the action of L-glutamate on metabotropic glutamate receptors. L-glutamate, released from photoreceptors, acts via Group III mGluR6 that via G o closes nonselective cation channels resulting in hyperpolarization (Nawy & Jahr, 1990 , 1991 Shiells & Falck, 1990; Thoreson & Witkovsky, 1999, for review) . Recently, Snellman and Nawy (2004) reported that cGMP activates a cGMP-dependent kinase that uncouples mGluR6 from the transduction channel in mouse ON bipolar cells. The effect is to reduce the ability of glutamate to maintain the cation channel in the open state, thereby permitting the bipolar cell to detect small changes in glutamate levels. However, there are far less data on G protein-mediated modulation of voltage-gated conductances in bipolar cells. Dopamine D 1 receptor activation results in an enhancement of I Ca and I K in goldfish Mb bipolar cells (Heidelberger & Matthews, 1994; Fan & Yazulla, 1999b) , whereas CB 1 receptor activation suppresses I Ca in salamander bipolar cells (Straiker et al., 1999) and I K in goldfish Mb bipolar cells (Yazulla et al., 2000) . Suppression of I Ca has been reported for substance P, somatostatin, met-and leu-enkephalin, and VIP in bipolar cells of goldfish (Ayoub & Matthews, 1992) and for somatostatin in rat and rabbit (Johnson et al., 2001; Petrucci et al., 2001) . Involvement of G proteins in the peptide-induced effects, though suggestive, were somewhat equivocal. This is the first report of which we are aware that has demonstrated an interaction of transmitter-induced G protein-mediated effects on voltage-gated conductances in bipolar cells. Such interactions have been described recently in goldfish cones (Fan & Yazulla, 2004) and, as discussed below, appear to be common features in other parts of the brain.
Common features of cannabinoid/dopamine interactions in the brain
Endocannabinoids interact with all the major transmitter systems in the brain. The major effect appears to be the modulation, either directly or indirectly, of the release of transmitters, including glutamate, GABA, acetylcholine, dopamine, and endorphins. The influence of the endocannabinoids has been implicated in numerous functions, including learning, memory, motor control, pain, appetite, emesis, opiate and cocaine addiction and withdrawal, among others (Ameri, 1999; Fride, 2002; DePetrocellis et al., 2004 , for reviews). Regarding a direct interaction of endocannabinoids and dopamine, CB 1 receptors are reportedly coexpressed with dopamine D 1 and0or D 2 receptors in the mammalian basal ganglia, striatum, hippocampus, and olfactory tubercle (e.g., Meschler & Howlett, 2001; Hermann et al., 2002; Julian et al., 2003) . Ordinarily, activation of CB 1 receptors or D 2 receptors inhibit adenylate cyclase via G protein G i0o . However, saturating concentrations of CB 1 and D 2 agonists did not completely suppress adenylate cyclase activity in striatal membranes and, in addition, were not additive, indicating action through a common transduction pathway (Meschler & Howlett, 2001) . In contrast, coexpression of CB 1 and D 1 agonists resulted in mutual antagonism, with CB 1 receptors still acting via G i0o and D 1 receptors acting via G s (Meschler & Howlett, 2001 (Yazulla et al., 2000) and is consistent with the data of Straiker et al. (1999) who showed inhibition of I Ca by 0.6 mM WIN 55212-2 in bipolar cells of salamander retina. At least then for bipolar cells of goldfish and tiger salamander, cannabinoid agonists inhibit voltage-gated currents. WIN 55212-2 (Յ1mM) had no effect of its own on I K(V) of Mb bipolar cells. However, when coapplied with 10 mM dopamine, WIN 55212-2 blocked the effect of dopamine at 1 mM and when applied prior to dopamine WIN 55212-2 was effective at 0.1 mM! We suggest that the basal level of G s activation in Mb bipolar cells is normally low and consequently, activation of G i0o by low concentrations of WIN 55212-2 would have no effect unless there was a concomitant increase in G s ; for example, by stimulation of D 1 receptors.
Effects of dopamine and cannabinoid agonists on I K(V) occur within the physiological range of Mb bipolar cell function (; Ϫ25 to 0 mV). I K(V) would be activated during the ON portion of the response and, as a counter current, would modulate the peak0 plateau ratio of the response. All things being equal, CB1 receptor activation should make the Mb bipolar cell ON response more tonic by suppressing the hyperpolarizing effect of I K(V) , whereas D1 receptor activation should make the ON response more phasic by enhancing I K(V) . If, as we suggest, cannabinoids and dopamine constitute opposing modulators of retinal sensitivity, the effect on ganglion cells that are innervated by Mb bipolar cells should be relatively tonic responses in scotopic conditions and relatively phasic responses in photopic conditions.
Comparison with data obtained on cones
Cannabinoid and dopamine agonists also have antagonistic actions on membrane currents in goldfish cones, except that the G protein-transduction machinery is the opposite in cones compared to Mb bipolar cells (Fan & Yazulla, 2003 . A schematic summarizing these data for cones and bipolar cells is shown in Fig. 7 . Regarding cones, note that dopamine acts via D 2 receptors rather than D 1 receptors and thus the inhibitory D 2 effect is mediated by G i0o , while the enhancing CB 1 effect is mediated by G s . Note that experiments with native and recombinant CB 1 receptors have demonstrated the presence of a G s linkage to the CB 1 receptor (Glass & Felder, 1997; Manuef & Brotchie, 1997; Bonhaus et al., 1998; Calandra et al., 1999) , in addition to the more common linkage with G i0o as described above. A common feature for cones and Mb bipolar cells is that activation of the inhibitory G i0o pathway (D 2 -cones, CB 1 -Mb cells) has little effect on its own. However, once enhanced by the G s pathway, whether by CB 1 in cones or D 1 in Mb cells, the membrane currents are potently reduced by subsequent activation of the G i0o pathway. As with Mb cells, we suggest that the basal level of cAMP in cones is low, and consequently, activation of G i0o by D 2 agonists would have little effect unless there was a concomitant increase in G s by stimulation of CB 1 receptors.
The concentration range of WIN 55212-2 at which its effects on cones and Mb bipolar cells are opposite to that of dopamine is about 0.1 to 1 mM. This comparable concentration range for acting on both cell types suggests a relatively uniform endocannabinoid concentration that is maintained throughout the retina for any given adaptive state. The endocannabinoids may then be opposed by reciprocal fluctuations in the concentration of retinal dopamine, such that the endocannabinoid0dopamine ratio is more relevant than absolute concentrations of either. Dopamine in retinas of teleost fish is found in a single type of interplexiform cell that arborizes in both the inner and outer plexiform layers (Dowling & Ehinger, 1978; Djamgoz & Wagner, 1992, for review) . Retinal dopamine content is higher in subjective day and increases in response to flashing lights by a factor of at least 4-fold in fish and frog retinas (e.g. Kirsch & Wagner, 1989; Witkovsky et al., 1993) . One endocannabinoid, 2-arachydonlyl glycerol, has been detected in rat retina (Straiker et al., 1999) . Hydrolysis of anandamide by fatty acid amide hydrolase has been reported in rat and goldfish retinas (Matsuda et al., 1997; Glaser et al., 2002) . However, the source and identity of putative retinal endocannabinoids are unknown. In addition, there are no data as to the light0circadian dependency of any endocannabinoid levels in the retina. We suggest that retinal endocannabinoids set a tone of excitability that is opposed by the relative concentration of dopamine that is modulated by circadian and light-dependent factors.
Concluding remarks
In summary, voltage-dependent currents (I K(V) and I Ca ) of cones and bipolar cells are subject to antagonistic influences from dopamine and cannabinoid agonists. As dopamine serves as a retinal "light" signal, these data support our hypothesis that endocannabinoids serve as a counter "dark" signal and interact with the dopamine system to adjust retinal sensitivity to changes in background illumination. At the earliest stages of neural processing, whether in cones or bipolar cells, the interactions of cannabinoids and dopamine have profound influence on membrane currents that would alter response waveform and transmitter release. Exactly how retinal sensitivity would be modulated as reflected in ganglion cell output, the electroretinogram, or in psychophysical tasks remains to be determined. It is very likely that some of the visual consequences of cannabis use have their origin in the retina. Cones: CB 1 receptors stimulate cAMP and enhance the currents via G s ; this action is countered by D 2 receptors that inhibit cAMP and reduce the currents via G i0o . In contrast for Mb bipolar cells: CB 1 receptors inhibit cAMP and reduce the currents via G i0o ; whereas, D 1 receptors stimulate cAMP and enhance the currents via G s .
